Search research articles
Contact Us
Filters
Showing results (201-210 of 425) with videos related to
Page
of 43
Sort By:
Expert Opinion on Investigational Drugs
|
April 20, 2018
The potential role of statins in preeclampsia and dyslipidemia during gestation: a narrative review
Serban M Maierean, Dimitri P Mikhailidis, Peter P Toth, et al.
Clinical Biochemistry
|
December 25, 2019
Corrigendum to "Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysis" [Clin. Biochem. 64 (2019) 24-29]
Michael K Palmer, Philip J Barter, Pia Lundman, et al.
Clinical Biochemistry
|
October 27, 2018
Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysis
Michael K Palmer, Philip J Barter, Pia Lundman, et al.
International Journal of Cardiology
|
April 26, 2016
Bioresorbable scaffold - A magic bullet for the treatment of coronary artery disease?
Daniel Brie, Peter Penson, Maria-Corina Serban, et al.
Clinical Cardiology
|
October 16, 2018
Protecting the gains: What changes are needed to prevent a reversal of the downward cardiovascular disease mortality trend?
Jesse D Ortendahl, Allison L Diamant, Peter P Toth, et al.
European Heart Journal
|
August 31, 2018
Association between phenotypic familial hypercholesterolaemia and telomere length in US adults: results from a multi-ethnic survey
Maciej Banach, Mohsen Mazidi, Dimitri P Mikhailidis, et al.
Cardiovascular Diabetology
|
September 18, 2012
The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus
Peter P Toth, Robert J Simko, Swetha Rao Palli, et al.
Atherosclerosis
|
June 24, 2014
Cardiovascular risk in patients achieving low-density lipoprotein cholesterol and particle targets
Peter P Toth, Michael Grabner, Rajeshwari S Punekar, et al.
Lipids in Health and Disease
|
March 24, 2016
Erratum to: Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study
Anna Gluba-Brzózka, Marta Michalska-Kasiczak, Beata Franczyk, et al.
Frontiers in Cardiovascular Medicine
|
September 18, 2023
Global eligibility and cost effectiveness of icosapent ethyl in primary and secondary cardiovascular prevention
Peter P Toth, Jean Ferrières, Max Waters, et al.
Page
of 43
Search research articles
Search
Showing results (201-210 of 425) with videos related to
Sort By:
Page
of 43
Expert Opinion on Investigational Drugs
|
April 20, 2018
The potential role of statins in preeclampsia and dyslipidemia during gestation: a narrative review
Serban M Maierean, Dimitri P Mikhailidis, Peter P Toth, et al.
Clinical Biochemistry
|
December 25, 2019
Corrigendum to "Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysis" [Clin. Biochem. 64 (2019) 24-29]
Michael K Palmer, Philip J Barter, Pia Lundman, et al.
Clinical Biochemistry
|
October 27, 2018
Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysis
Michael K Palmer, Philip J Barter, Pia Lundman, et al.
International Journal of Cardiology
|
April 26, 2016
Bioresorbable scaffold - A magic bullet for the treatment of coronary artery disease?
Daniel Brie, Peter Penson, Maria-Corina Serban, et al.
Clinical Cardiology
|
October 16, 2018
Protecting the gains: What changes are needed to prevent a reversal of the downward cardiovascular disease mortality trend?
Jesse D Ortendahl, Allison L Diamant, Peter P Toth, et al.
European Heart Journal
|
August 31, 2018
Association between phenotypic familial hypercholesterolaemia and telomere length in US adults: results from a multi-ethnic survey
Maciej Banach, Mohsen Mazidi, Dimitri P Mikhailidis, et al.
Cardiovascular Diabetology
|
September 18, 2012
The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus
Peter P Toth, Robert J Simko, Swetha Rao Palli, et al.
Atherosclerosis
|
June 24, 2014
Cardiovascular risk in patients achieving low-density lipoprotein cholesterol and particle targets
Peter P Toth, Michael Grabner, Rajeshwari S Punekar, et al.
Lipids in Health and Disease
|
March 24, 2016
Erratum to: Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study
Anna Gluba-Brzózka, Marta Michalska-Kasiczak, Beata Franczyk, et al.
Frontiers in Cardiovascular Medicine
|
September 18, 2023
Global eligibility and cost effectiveness of icosapent ethyl in primary and secondary cardiovascular prevention
Peter P Toth, Jean Ferrières, Max Waters, et al.
Page
of 43